-
1
-
-
0033303824
-
Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ culture
-
Ahonen TJ, Harkonen PL, Laine J, Rui H, Martikainen PM, Nevalainen MT (1999) Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ culture. Endocrinology 140: 5412-5421
-
(1999)
Endocrinology
, vol.140
, pp. 5412-5421
-
-
Ahonen, T.J.1
Harkonen, P.L.2
Laine, J.3
Rui, H.4
Martikainen, P.M.5
Nevalainen, M.T.6
-
2
-
-
0027366454
-
Characterization of a monoclonal antibody against human prolactin receptors
-
DOI 10.1002/ijc.2910550503
-
Banerjee R, Ginsburg E, Vonderhaar BK (1993) Characterization of a monoclonal antibody against human prolactin receptors. Int J Cancer 55: 712-721 (Pubitemid 23354882)
-
(1993)
International Journal of Cancer
, vol.55
, Issue.5
, pp. 712-721
-
-
Banerjee, R.1
Ginsburg, E.2
Vonderhaar, B.K.3
-
3
-
-
0036673766
-
Prolactin as an autocrine/paracrine growth factor in human cancer
-
DOI 10.1016/S1043-2760(02)00603-3, PII S1043276002006033
-
Ben-Jonathan N, Liby K, McFarland M, Zinger M (2002) Prolactin as an autocrine/paracrine growth factor in human cancer. Trends Endocrinol Metab 13: 245-250 (Pubitemid 36733969)
-
(2002)
Trends in Endocrinology and Metabolism
, vol.13
, Issue.6
, pp. 245-250
-
-
Ben-Jonathan, N.1
Liby, K.2
McFarland, M.3
Zinger, M.4
-
4
-
-
0030451788
-
Extra-pituitary prolactin: Distribution, regulation, functions, and clinical aspects
-
Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW (1996) Extra-pituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17: 639-669
-
(1996)
Endocr Rev
, vol.17
, pp. 639-669
-
-
Ben-Jonathan, N.1
Mershon, J.L.2
Allen, D.L.3
Steinmetz, R.W.4
-
5
-
-
0027283344
-
Circulating markers and growth factors as prognosticators in men with advanced tongue cancer
-
Bhatavdekar JM, Patel DD, Vora HH, Balar DB (1993) Circulating markers and growth factors as prognosticators in men with advanced tongue cancer. Tumour Biol 14: 55-58 (Pubitemid 23192951)
-
(1993)
Tumor Biology
, vol.14
, Issue.1
, pp. 55-58
-
-
Bhatavdekar, J.M.1
Patel, D.D.2
Vora, H.H.3
Balar, D.B.4
-
6
-
-
0033994932
-
Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience
-
DOI 10.10 02/(SI CI)1097-034 7(2000 05)22:3<25 7::AID-HE D8>3.0.CO;2-K
-
Bhatavdekar JM, Patel DD, Vora HH, Shah NG, Chikhlikar PR, Ghosh N (2000) Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience. Head Neck 22: 257-264 (Pubitemid 30215322)
-
(2000)
Head and Neck
, vol.22
, Issue.3
, pp. 257-264
-
-
Bhatavdekar, J.M.1
Patel, D.D.2
Vora, H.H.3
Shah, N.G.4
Chikhlikar, P.R.5
Ghosh, N.6
-
7
-
-
33747876154
-
Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells
-
DOI 10.1677/joe.1.06368
-
Bishop JD, Nien WL, Dauphinee SM, Too CK (2006) Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells. J Endocrinol 190: 307-312 (Pubitemid 44288368)
-
(2006)
Journal of Endocrinology
, vol.190
, Issue.2
, pp. 307-312
-
-
Bishop, J.D.1
Nien, W.L.2
Dauphinee, S.M.3
Too, C.K.L.4
-
8
-
-
0023191190
-
Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture
-
Biswas R, Vonderhaar BK (1987) Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture. Cancer Res 47: 3509-3514 (Pubitemid 17096011)
-
(1987)
Cancer Research
, vol.47
, Issue.13
, pp. 3509-3514
-
-
Biswas, R.1
Vonderhaar, B.K.2
-
9
-
-
67349104572
-
Complex prolactin crosstalk in breast cancer: New therapeutic implications
-
Carver KC, Arendt LM, Schuler LA (2009) Complex prolactin crosstalk in breast cancer: new therapeutic implications. Mol Cell Endocrinol 307: 1-7
-
(2009)
Mol Cell Endocrinol
, vol.307
, pp. 1-7
-
-
Carver, K.C.1
Arendt, L.M.2
Schuler, L.A.3
-
10
-
-
77950873516
-
Prolactin enhances insulin-like growth factor i receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells
-
Carver KC, Piazza TM, Schuler LA (2010) Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells. J Biol Chem 285: 8003-8012
-
(2010)
J Biol Chem
, vol.285
, pp. 8003-8012
-
-
Carver, K.C.1
Piazza, T.M.2
Schuler, L.A.3
-
11
-
-
4444255613
-
Role of prolactin/prolactin receptor signaling in human breast cancer
-
Clevenger CV (2003) Role of prolactin/prolactin receptor signaling in human breast cancer. Breast Dis 18: 75-86 (Pubitemid 39193333)
-
(2003)
Breast Disease
, vol.18
, pp. 75-86
-
-
Clevenger, C.V.1
-
13
-
-
40249111487
-
From bench to bedside: Future potential for the translation of prolactin inhibitors as breast cancer therapeutics
-
Clevenger CV, Zheng J, Jablonski EM, Galbaugh TL, Fang F (2008) From bench to bedside: future potential for the translation of prolactin inhibitors as breast cancer therapeutics. J Mammary Gland Biol Neoplasia 13: 147-156
-
(2008)
J Mammary Gland Biol Neoplasia
, vol.13
, pp. 147-156
-
-
Clevenger, C.V.1
Zheng, J.2
Jablonski, E.M.3
Galbaugh, T.L.4
Fang, F.5
-
14
-
-
77953436551
-
Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1
-
Creamer BA, Sakamoto K, Schmidt JW, Triplett AA, Moriggl R, Wagner KU (2010) Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1. Mol Cell Biol 30: 2957-2970
-
(2010)
Mol Cell Biol
, vol.30
, pp. 2957-2970
-
-
Creamer, B.A.1
Sakamoto, K.2
Schmidt, J.W.3
Triplett, A.A.4
Moriggl, R.5
Wagner, K.U.6
-
15
-
-
34347271908
-
Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway
-
DOI 10.1210/en.2006-1761
-
Dagvadorj A, Collins S, Jomain JB, Abdulghani J, Karras J, Zellweger T, Li H, Nurmi M, Alanen K, Mirtti T, Visakorpi T, Bubendorf L, Goffin V, Nevalainen MT (2007) Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcrip-tion-5a/b signaling pathway. Endocrinology 148: 3089-3101 (Pubitemid 46996970)
-
(2007)
Endocrinology
, vol.148
, Issue.7
, pp. 3089-3101
-
-
Dagvadorj, A.1
Collins, S.2
Jomain, J.-B.3
Abdulghani, J.4
Karras, J.5
Zellweger, T.6
Li, H.7
Nurmi, M.8
Alanen, K.9
Mirtti, T.10
Visakorpi, T.11
Bubendorf, L.12
Goffin, V.13
Nevalainen, M.T.14
-
16
-
-
40949103423
-
Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo
-
DOI 10.1158/1078-0432.CCR-07-2024
-
Dagvadorj A, Kirken RA, Leiby B, Karras J, Nevalainen MT (2008) Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo. Clin Cancer Res 14: 1317-1324 (Pubitemid 351413910)
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.5
, pp. 1317-1324
-
-
Dagvadorj, A.1
Kirken, R.A.2
Leiby, B.3
Karras, J.4
Nevalainen, M.T.5
-
17
-
-
34547820916
-
Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migration
-
DOI 10.1677/ERC-06-0050
-
Doll F, Pfeilschifter J, Huwiler A (2007) Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migration. Endocr Relat Cancer 14: 325-335 (Pubitemid 47242633)
-
(2007)
Endocrine-Related Cancer
, vol.14
, Issue.2
, pp. 325-335
-
-
Doll, F.1
Pfeilschifter, J.2
Huwiler, A.3
-
18
-
-
0034454903
-
The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: Insights from genetic models of hormone and hormone receptor deficiency
-
DOI 10.1210/er.21.3.292
-
Dorshkind K, Horseman ND (2000) The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr Rev 21: 292-312 (Pubitemid 32275590)
-
(2000)
Endocrine Reviews
, vol.21
, Issue.3
, pp. 292-312
-
-
Dorshkind, K.1
Horseman, N.D.2
-
19
-
-
67349193700
-
Prolactin and the skin: A dermatological perspective on an ancient pleiotropic peptide hormone
-
Foitzik K, Langan EA, Paus R (2009) Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone. J Invest Dermatol 129: 1071-1087
-
(2009)
J Invest Dermatol
, vol.129
, pp. 1071-1087
-
-
Foitzik, K.1
Langan, E.A.2
Paus, R.3
-
20
-
-
0029012232
-
Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines
-
Fuh G, Wells JA (1995) Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J Biol Chem 270: 13133-13137
-
(1995)
J Biol Chem
, vol.270
, pp. 13133-13137
-
-
Fuh, G.1
Wells, J.A.2
-
21
-
-
14344261454
-
Prolactin-induced expression of vascular endothelial growth factor via Egr-1
-
DOI 10.1016/j.mce.2005.01.005
-
Goldhar AS, Vonderhaar BK, Trott JF, Hovey RC (2005) Prolactin-induced expression of vascular endothelial growth factor via Egr-1. Mol Cell Endocrinol 232: 9-19 (Pubitemid 40292935)
-
(2005)
Molecular and Cellular Endocrinology
, vol.232
, Issue.1-2
, pp. 9-19
-
-
Goldhar, A.S.1
Vonderhaar, B.K.2
Trott, J.F.3
Hovey, R.C.4
-
22
-
-
77954244966
-
Clinicopathological significance of prolactin receptor expression in colorectal carcinoma and corresponding metastases
-
Harbaum L, Pollheimer MJ, Bauernhofer T, Kornprat P, Lindtner RA, Schlemmer A, Rehak P, Langner C (2010) Clinicopathological significance of prolactin receptor expression in colorectal carcinoma and corresponding metastases. Mod Pathol 23: 961-971
-
(2010)
Mod Pathol
, vol.23
, pp. 961-971
-
-
Harbaum, L.1
Pollheimer, M.J.2
Bauernhofer, T.3
Kornprat, P.4
Lindtner, R.A.5
Schlemmer, A.6
Rehak, P.7
Langner, C.8
-
23
-
-
51149123494
-
Adverse effects of prolactin in rodents and humans: Breast and prostate cancer
-
Harvey PW, Everett DJ, Springall CJ (2008) Adverse effects of prolactin in rodents and humans: breast and prostate cancer. J Psychopharmacol 22: 20-27
-
(2008)
J Psychopharmacol
, vol.22
, pp. 20-27
-
-
Harvey, P.W.1
Everett, D.J.2
Springall, C.J.3
-
24
-
-
0030910705
-
Prolactin signaling in mammary gland development
-
DOI 10.1074/jbc.272.12.7567
-
Hennighausen L, Robinson GW, Wagner KU, Liu W (1997) Prolactin signaling in mammary gland development. J Biol Chem 272: 7567-7569 (Pubitemid 27137300)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.12
, pp. 7567-7569
-
-
Hennighausen, L.1
Robinson, G.W.2
Wagner, K.-U.3
Liu, X.4
-
25
-
-
0024448596
-
Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines
-
Heo DS, Snyderman C, Gollin SM, Pan S, Walker E, Deka R, Barnes EL, Johnson JT, Herberman RB, Whiteside TL (1989) Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res 49: 5167-5175 (Pubitemid 19239363)
-
(1989)
Cancer Research
, vol.49
, Issue.18
, pp. 5167-5175
-
-
Heo, D.S.1
Snyderman, C.2
Gollin, S.M.3
Pan, S.4
Walker, E.5
Deka, R.6
Barnes, E.L.7
Johnson, J.T.8
Herberman, R.B.9
Whiteside, T.L.10
-
26
-
-
0031782810
-
A role for growth hormone and prolactin in leukaemia and lymphoma?
-
DOI 10.1007/s000180050238
-
Hooghe R, Merchav S, Gaidano G, Naessens F, Matera L (1998) A role for growth hormone and prolactin in leukaemia and lymphoma? Cell Mol Life Sci 54: 1095-1101 (Pubitemid 28491018)
-
(1998)
Cellular and Molecular Life Sciences
, vol.54
, Issue.10
, pp. 1095-1101
-
-
Hooghe, R.1
Merchav, S.2
Gaidano, G.3
Naessens, F.4
Matera, L.5
-
27
-
-
65849450483
-
Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity
-
Howell SJ, Anderson E, Hunter T, Farnie G, Clarke RB (2008) Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity. Breast Cancer Res 10: R68
-
(2008)
Breast Cancer Res
, vol.10
-
-
Howell, S.J.1
Anderson, E.2
Hunter, T.3
Farnie, G.4
Clarke, R.B.5
-
28
-
-
0031822837
-
Tissue microarrays for high-throughput molecular profiling of tumor specimens
-
DOI 10.1038/nm0798-844
-
Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847 (Pubitemid 28331029)
-
(1998)
Nature Medicine
, vol.4
, Issue.7
, pp. 844-847
-
-
Kononen, J.1
Bubendorf, L.2
Kallioniemi, A.3
Barlund, M.4
Schraml, P.5
Leighton, S.6
Torhorst, J.7
Mihatsch, M.J.8
Sauter, G.9
Kallioniemi, O.-P.10
-
29
-
-
17744378741
-
Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A
-
DOI 10.1007/s10549-004-4816-9
-
Langenheim JF, Chen WY (2005) Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A. Breast Cancer Res Treat 90: 281-293 (Pubitemid 40576842)
-
(2005)
Breast Cancer Research and Treatment
, vol.90
, Issue.3
, pp. 281-293
-
-
Langenheim, J.F.1
Chen, W.Y.2
-
30
-
-
69449103357
-
Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase
-
LaPensee EW, Schwemberger SJ, LaPensee CR, Bahassiel M, Afton SE, Ben-Jonathan N (2009) Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase. Carcinogen-esis 30: 1298-1304
-
(2009)
Carcinogen-esis
, vol.30
, pp. 1298-1304
-
-
Lapensee, E.W.1
Schwemberger, S.J.2
Lapensee, C.R.3
Bahassiel, M.4
Afton, S.E.5
Ben-Jonathan, N.6
-
31
-
-
0028858647
-
Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth
-
Lin WC, Yasumura S, Suminami Y, Sung MW, Nagashima S, Stanson J, Whiteside TL (1995) Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth. J Immunol 155: 4805-4816
-
(1995)
J Immunol
, vol.155
, pp. 4805-4816
-
-
Lin, W.C.1
Yasumura, S.2
Suminami, Y.3
Sung, M.W.4
Nagashima, S.5
Stanson, J.6
Whiteside, T.L.7
-
32
-
-
42549096464
-
Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma
-
DOI 10.1038/modpathol.2008.7, PII MODPATHOL20087
-
McHale K, Tomaszewski JE, Puthiyaveettil R, Livolsi VA, Clevenger CV (2008) Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma. Mod Pathol 21: 565-571 (Pubitemid 351589663)
-
(2008)
Modern Pathology
, vol.21
, Issue.5
, pp. 565-571
-
-
McHale, K.1
Tomaszewski, J.E.2
Puthiyaveettil, R.3
Livolsi, V.A.4
Clevenger, C.V.5
-
33
-
-
18344401383
-
Cellular expression of growth hormone and prolactin receptors in human breast disorders
-
DOI 10.10 02/(SICI)10 97-0215(199 80417)79:2<20 2::AID-IJC 17>3.0.CO;2-B
-
Mertani HC, Garcia-Caballero T, Lambert A, Gerard F, Palayer C, Boutin JM, Vonderhaar BK, Waters MJ, Lobie PE, Morel G (1998) Cellular expression of growth hormone and prolactin receptors in human breast disorders. Int J Cancer 79: 202-211 (Pubitemid 28201694)
-
(1998)
International Journal of Cancer
, vol.79
, Issue.2
, pp. 202-211
-
-
Mertani, H.C.1
Garcia-Caballero, T.2
Lambert, A.3
Gerard, F.4
Palayer, C.5
Boutin, J.-M.6
Vonderhaar, B.K.7
Waters, M.J.8
Lobie, P.E.9
Morel, G.10
-
34
-
-
76049092026
-
Serum prognostic markers in head and neck cancer
-
Meyer F, Samson E, Douville P, Duchesne T, Liu G, Bairati I (2010) Serum prognostic markers in head and neck cancer. Clin Cancer Res 16: 1008-1015
-
(2010)
Clin Cancer Res
, vol.16
, pp. 1008-1015
-
-
Meyer, F.1
Samson, E.2
Douville, P.3
Duchesne, T.4
Liu, G.5
Bairati, I.6
-
35
-
-
0028301308
-
Circulating prolactin and tumoral prolactin receptors in men with tongue cancer: A preliminary study
-
Patel DD, Bhatavdekar JM, Vora HH, Balar DB (1994) Circulating prolactin and tumoral prolactin receptors in men with tongue cancer: a preliminary study. Eur J Surg Oncol 20: 155-159 (Pubitemid 24164471)
-
(1994)
European Journal of Surgical Oncology
, vol.20
, Issue.2
, pp. 155-159
-
-
Patel, D.D.1
Bhatavdekar, J.M.2
Vora, H.H.3
Balar, D.B.4
-
36
-
-
63849316576
-
Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulation
-
Perotti C, Liu R, Parusel CT, Bocher N, Schultz J, Bork P, Pfitzner E, Groner B, Shemanko CS (2008) Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulation. Breast Cancer Res 10: R94
-
(2008)
Breast Cancer Res
, vol.10
-
-
Perotti, C.1
Liu, R.2
Parusel, C.T.3
Bocher, N.4
Schultz, J.5
Bork, P.6
Pfitzner, E.7
Groner, B.8
Shemanko, C.S.9
-
37
-
-
66149095511
-
Impaired turnover of prolactin receptor contributes to transformation of human breast cells
-
Plotnikov A, Varghese B, Tran TH, Liu C, Rui H, Fuchs SY (2009) Impaired turnover of prolactin receptor contributes to transformation of human breast cells. Cancer Res 69: 3165-3172
-
(2009)
Cancer Res
, vol.69
, pp. 3165-3172
-
-
Plotnikov, A.1
Varghese, B.2
Tran, T.H.3
Liu, C.4
Rui, H.5
Fuchs, S.Y.6
-
38
-
-
77953489794
-
Prolactin - A novel neuroendocrine regulator of human keratin expression in situ
-
Ramot Y, Biro T, Tiede S, Toth BI, Langan EA, Sugawara K, Foitzik K, Ingber A, Goffin V, Langbein L, Paus R (2010) Prolactin - a novel neuroendocrine regulator of human keratin expression in situ. FASEB J 24: 1768-1779
-
(2010)
FASEB J
, vol.24
, pp. 1768-1779
-
-
Ramot, Y.1
Biro, T.2
Tiede, S.3
Toth, B.I.4
Langan, E.A.5
Sugawara, K.6
Foitzik, K.7
Ingber, A.8
Goffin, V.9
Langbein, L.10
Paus, R.11
-
39
-
-
0033330658
-
Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells
-
Russell DL, Richards JS (1999) Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells. Mol Endocrinol 13: 2049-2064 (Pubitemid 30637266)
-
(1999)
Molecular Endocrinology
, vol.13
, Issue.12
, pp. 2049-2064
-
-
Russell, D.L.1
Richards, J.S.2
-
40
-
-
40249102092
-
Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells
-
Scotti ML, Langenheim JF, Tomblyn S, Springs AE, Chen WY (2008) Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells. Breast Cancer Res Treat 111: 241-250
-
(2008)
Breast Cancer Res Treat
, vol.111
, pp. 241-250
-
-
Scotti, M.L.1
Langenheim, J.F.2
Tomblyn, S.3
Springs, A.E.4
Chen, W.Y.5
-
41
-
-
67649438663
-
Combination therapy using three novel prolactin receptor antagonist-based fusion proteins effectively inhibits tumor recurrence and metastasis in HER2/ neu transgenic mice
-
Tomblyn S, Springs AE, Langenheim JF, Chen WY (2009) Combination therapy using three novel prolactin receptor antagonist-based fusion proteins effectively inhibits tumor recurrence and metastasis in HER2/ neu transgenic mice. Int J Oncol 34: 1139-1146
-
(2009)
Int J Oncol
, vol.34
, pp. 1139-1146
-
-
Tomblyn, S.1
Springs, A.E.2
Langenheim, J.F.3
Chen, W.Y.4
-
42
-
-
34248190678
-
A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer
-
DOI 10.1200/JCO.2006.07.6356
-
Tworoger SS, Eliassen AH, Sluss P, Hankinson SE (2007) A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol 25: 1482-1488 (Pubitemid 46733075)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.12
, pp. 1482-1488
-
-
Tworoger, S.S.1
Eliassen, A.H.2
Sluss, P.3
Hankinson, S.E.4
-
43
-
-
40249102994
-
Prolactin and breast cancer etiology: An epidemiologic perspective
-
Tworoger SS, Hankinson SE (2008) Prolactin and breast cancer etiology: an epidemiologic perspective. J Mammary Gland Biol Neoplasia 13: 41-53
-
(2008)
J Mammary Gland Biol Neoplasia
, vol.13
, pp. 41-53
-
-
Tworoger, S.S.1
Hankinson, S.E.2
|